Net sales (including related party sales of 4,879 and 7,647 in the three months ended march 31, 2026 and 2025, respectively, and 23,940 and 33,799 in the nine months ended march 31, 2026 and 2025, respectively)
10,243,014
12,682,491
5,017,790
5,756,911
Cost of sales (including related party purchases of 202,840 and 115,519 in the three months ended march 31, 2026 and 2025, respectively, and 549,962 and 491,680 in the nine months ended march 31, 2026 and 2025, respectively)
9,224,334
11,883,924
4,550,417
5,212,809
Gross profit
1,018,680
798,567
467,373
544,102
Research and development
215,659
180,761
173,314
183,221
Sales and marketing
89,510
73,078
47,928
64,739
General and administrative
87,643
70,430
63,875
67,751
Total operating expenses
392,812
324,269
285,117
315,711
Income from operations
625,868
474,298
182,256
228,391
Other income (expense), net
4,147
225
-
-
Other income, net
-
-
51,227
16,616
Interest income
45,437
51,042
-
-
Interest expense
64,483
25,358
24,931
22,282
Income before income tax provision
610,969
500,207
208,552
222,725
Income tax provision
126,887
99,151
40,161
19,307
Share of (loss) income from equity investee, net of taxes
-695
-492
-106
-8,264
Net income
483,387
400,564
168,285
195,154
Basic EPS
0.81
0.67
0.28
0.327
Diluted EPS
0.72
0.6
0.26
0.316
Basic Average Shares
600,205,000
598,004,000
595,624,000
597,554,000
Diluted Average Shares
692,189,000
693,989,000
663,235,000
616,604,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.